Page last updated: 2024-08-25

cp094 and Skin Neoplasms

cp094 has been researched along with Skin Neoplasms in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (50.00)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anayo, L; Curnow, A; Magnussen, A; Perry, A; Wood, M1
Curnow, A; Perry, A; Wood, M1
Alyahya, R; Campbell, SM; Curnow, A; Horton, S; Morton, CA; Pye, A1
Albertin, A; La Colla, L; Mangano, A1
Campbell, SM; Curnow, A1
Campbell, S; Curnow, A; Pye, A1

Trials

2 trial(s) available for cp094 and Skin Neoplasms

ArticleYear
Clinical investigation of the novel iron-chelating agent, CP94, to enhance topical photodynamic therapy of nodular basal cell carcinoma.
    The British journal of dermatology, 2008, Volume: 159, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Basal Cell; Dose-Response Relationship, Drug; Female; Humans; Iron Chelating Agents; Male; Middle Aged; Pain; Photochemotherapy; Photosensitizing Agents; Pilot Projects; Pyridones; Skin Neoplasms; Treatment Outcome

2008
Enhancement of methyl-aminolevulinate photodynamic therapy by iron chelation with CP94: an in vitro investigation and clinical dose-escalating safety study for the treatment of nodular basal cell carcinoma.
    Journal of cancer research and clinical oncology, 2008, Volume: 134, Issue:8

    Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Basal Cell; Cell Line, Tumor; Humans; In Vitro Techniques; Iron Chelating Agents; Middle Aged; Photochemotherapy; Photosensitizing Agents; Pilot Projects; Protoporphyrins; Pyridones; Skin Neoplasms

2008

Other Studies

4 other study(ies) available for cp094 and Skin Neoplasms

ArticleYear
An experimental investigation of a novel iron chelating protoporphyrin IX prodrug for the enhancement of photodynamic therapy.
    Lasers in surgery and medicine, 2018, Volume: 50, Issue:5

    Topics: Carcinoma, Squamous Cell; Cell Culture Techniques; Epithelial Cells; Fibroblasts; Humans; Iron Chelating Agents; Photochemotherapy; Photosensitizing Agents; Prodrugs; Protoporphyrins; Pyridones; Skin Neoplasms

2018
Improving in vitro photodynamic therapy through the development of a novel iron chelating aminolaevulinic acid prodrug.
    Photodiagnosis and photodynamic therapy, 2019, Volume: 25

    Topics: Aminolevulinic Acid; Cell Line, Tumor; Cell Survival; Humans; Iron Chelating Agents; Photochemotherapy; Photosensitizing Agents; Prodrugs; Protoporphyrins; Pyridones; Skin Neoplasms

2019
Clinical investigation of the novel iron-chelating agent, CP94, to enhance topical photodynamic therapy of nodular basal cell carcinoma: when statistics make a difference.
    The British journal of dermatology, 2009, Volume: 161, Issue:1

    Topics: Carcinoma, Basal Cell; Humans; Iron Chelating Agents; Photochemotherapy; Photosensitizing Agents; Pilot Projects; Pyridones; Sample Size; Skin Neoplasms

2009
Clinical investigation of the novel iron-chelating agent, CP94, to enhance topical photodynamic therapy of nodular basal cell carcinoma: further explanation of a dose-escalating pilot study conducted primarily to consider the safety of this pharmacologica
    The British journal of dermatology, 2010, Volume: 162, Issue:1

    Topics: Carcinoma, Basal Cell; Dose-Response Relationship, Drug; Humans; Iron Chelating Agents; Photochemotherapy; Photosensitizing Agents; Pilot Projects; Pyridones; Skin Neoplasms

2010